Adenoid Cystic Carcinoma — Trials, FDA Actions & Pivotal Research

19 active Adenoid Cystic Carcinoma trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: June 12, 2026.

Recruiting trials by city

Cities where Adenoid Cystic Carcinoma trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.

Boston, MA San Francisco, CA Ann Arbor, MI Santa Rosa, CA

Active Adenoid Cystic Carcinoma trials

Currently recruiting US trials matching Adenoid Cystic Carcinoma, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

Sponsor: Eye & ENT Hospital of Fudan University

Sex: All·Age: 18 - 75

Code: NCT07616141·Phase 2·Not Yet Recruiting

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

for Recurrent Adenoid Cystic Carcinoma

Sponsor: National Cancer Centre, Singapore

Sex: All·Age: 18 - 99

Code: NCT07521670·Phase 2·Not Yet Recruiting

A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

Sponsor: Eye & ENT Hospital of Fudan University

Sex: All·Age: 18+

Code: NCT07522879·Phase 2·Recruiting

Apply to this trial

SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

Sponsor: Eye & ENT Hospital of Fudan University

Sex: All·Age: 18 - 75

Code: NCT07563088·Not Yet Recruiting

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

for Adenoid Cystic Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07162480·Phase 2·Recruiting

Apply to this trial

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

for Adenoid Cystic Carcinoma

Sponsor: Eye & ENT Hospital of Fudan University

Sex: All·Age: 18 - 70

Code: NCT07320508·Phase 2·Recruiting

Apply to this trial

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06891560·Phase 2·Recruiting

Apply to this trial

A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

for Salivary Gland Cancer

2 locations incl. Boston

Sponsor: Glenn J. Hanna

Sex: All·Age: 18+

Code: NCT06805617·Phase 2·Recruiting

Apply to this trial

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for Gastrointestinal Stromal Tumors

5 locations incl. Ann Arbor

Sponsor: Novelty Nobility, Inc.

Sex: All·Age: 18+

Code: NCT06805825·Phase 1·Recruiting

Apply to this trial

Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

Sponsor: HitGen Inc.

Sex: All·Age: 18+

Code: NCT06781567·Phase 2·Recruiting

Apply to this trial

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

for Adenoid Cystic Carcinoma

8 locations incl. Boston

Sponsor: Rgenta Therapeutics Inc

Sex: All·Age: 18+

Code: NCT06462183·Phase 1·Recruiting

Apply to this trial

Agnostic Therapy in Rare Solid Tumors

for Urachal Cancer

Sponsor: Instituto do Cancer do Estado de São Paulo

Sex: All·Age: 18+

Code: NCT06638931·Phase 2·Recruiting

Apply to this trial

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

6 locations incl. San Francisco

Sponsor: Remix Therapeutics

Sex: All·Age: 18+

Code: NCT06118086·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

for Adrenocortical Carcinoma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06066333·Phase 2·Recruiting

Apply to this trial

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

for Adenoid Cystic Carcinoma

1 location in Boston

Sponsor: Glenn J. Hanna

Sex: All·Age: 18+

Code: NCT05774899·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of XMT-1660 in Participants With Solid Tumors

for Triple Negative Breast Cancer

26 locations incl. Phoenix

Sponsor: Mersana Therapeutics

Sex: All·Age: 18+

Code: NCT05377996·Phase 1·Recruiting

Apply to this trial

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

for Adenoid Cystic Carcinoma

5 locations incl. San Francisco

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04883671·Recruiting

Apply to this trial

Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation

for Adenoid Cystic Carcinoma

Sponsor: Heidelberg University

Sex: All·Age: 18 - 80

Code: NCT04214366·Phase 2·Recruiting

Apply to this trial

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for Head and Neck Carcinoma

14 locations incl. Santa Rosa

Sponsor: VM Oncology, LLC

Sex: All·Age: 18 - 80

Code: NCT03556228·Phase 1, Phase 2·Recruiting

Apply to this trial